Send us Feedback

Cardium Therapeutics Inc (CXM)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
PR Newswire  May 17  Comment 
SAN DIEGO, May 17, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) today announced that Christopher J. Reinhard, Chairman & CEO will present a corporate overview and participate in a Regenerative Medicine Panel being held at the Sachs 2012
Cardium Reports New Catheter-Based Methods Significantly Boost Cardiac Gene Delivery In Late-Breaking Presentation at 2012 American Society of Gene & Cell Therapy Meeting
PR Newswire  May 16  Comment 
SAN DIEGO, May 16, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) today announced a late-breaking poster presentation at the American Society of Gene & Cell Therapy (ASGCT) 15th Annual Meeting being held May 16-19, 2012 at the Pennsylvania
Cardium Therapeutics (CXM) Reports In-Line Q1 Loss of 2c/Share
StreetInsider.com  May 15  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Cardium+Therapeutics+%28CXM%29+Reports+In-Line+Q1+Loss+of+2cShare/7438745.html for the full story.
Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
PR Newswire  May 15  Comment 
SAN DIEGO, May 15, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced an agreement with UK-based Angel Biomedical Limited, a subsidiary of Angel Biotechnology Holdings plc (AIM: ABH), a global biopharmaceutical contract
Cardium Therapeutics (CXM) Enters Excellagen Agreement with Angel Biomedical
StreetInsider.com  May 15  Comment 
Cardium Presents First Quarter 2012 Financial Results and Recent Developments
PR Newswire  May 15  Comment 
SAN DIEGO, May 15, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today presented its financial results for the first quarter ended March 31, 2012, and other recent developments. (Logo:
PetroBakken Energy profit up on higher Cardium production
Reuters  May 2  Comment 
PetroBakken Energy Ltd's first-quarter profit rose more than four-fold, helped in part by higher production from its Cardium light oil play in central Alberta.
Cardium Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care
PR Newswire  Apr 19  Comment 
SAN DIEGO, April 19, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) is currently exhibiting its new FDA-cleared Excellagen(®) professional-use, syringe-based wound care product for the management of diabetic foot ulcers, pressure ulcers
Vero Energy raises 2012 output on Cardium success
Reuters  Apr 10  Comment 
Vero Energy Inc raised its 2012 production forecast as output from the Cardium assets in Alberta increased in the first quarter, helped by higher number of wells drilled.
Smith Medical Partners Announces Logistics Agreement for Cardium's National Distribution of Excellagen(TM)
PR Newswire  Apr 2  Comment 
WOOD DALE, Ill., April 2, 2012 /PRNewswire/ -- Smith Medical Partners, the specialty pharmaceutical subsidiary of H. D. Smith, today announced an exclusive logistics and cold chain services agreement with Cardium Therapeutics (NYSE Amex: CXM), a
Cardium Presents Fourth Quarter and Year-End 2011 Financial Results and Recent Developments
PR Newswire  Mar 30  Comment 
SAN DIEGO, March 30, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE AMEX: CXM) today presented highlights of financial results for its fourth quarter and fiscal year ended December 31, 2011, and other recent developments and outlook for 2012. (Logo:




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 




References

Retrieved from "http://www.wikinvest.com/stock/Cardium_Therapeutics_Inc_(CXM)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki